Delivery Order 75N91021D00001-75N91022F00001
Award Date
12/15/21
Potential Completion Date
12/16/22
Potential Value
$31K
Federal Agency
National Cancer Institute
Awardee
Olink Proteomics AB
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Waltham, MA 02453, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This purchase order, valued at $77,330, was awarded by the National Institutes of Health's National Cancer Institute to Olink Proteomics Inc. to provide normalized expression data from multiplexed immunoassays using the Olink Explore 3072 platform. The services will support research conducted by the Pediatric Oncology Branch. As a sole source award under FAR Part 12, the contract calls for Olink to leverage its proprietary technology to deliver specialized proteomics analysis services to NIH/NCI...
Olink Proteomics AB was awarded a $78,190 firm fixed price delivery order by the National Cancer Institute, a component of the Department of Health and Human Services, to provide services evaluating circulating biomarkers in cancer. The delivery order was issued under an indefinite delivery/indefinite quantity contract vehicle to support the Division of Cancer Epidemiology and Genetics. Services will include evaluating circulating biomarkers to support the Division's research efforts....
Olink Proteomics AB has been awarded a $10,078.96 purchase order by the National Institutes of Health's National Cancer Institute to provide biological and reagent materials for direct use. The firm fixed price contract runs from November 29, 2023 through December 31, 2023 and will be performed in Waltham, Massachusetts. No major subcontractors or set aside designations were indicated. The materials will support the National Cancer Institute's mission to lead the National Cancer Program and...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $50,688 firm fixed price delivery order to Olink Proteomics AB of Waltham, Massachusetts. The order is for Olink Target-96 Immuno-Oncology Analysis Service in support of the agency's Center for Immunology-Oncology programs. Performance will take place in Waltham from August 1, 2023 through January 31, 2024. No subcontractors or set aside designations were indicated. The delivery order...
The National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, has awarded a $63,492 delivery order contract to Olink Proteomics AB. Under the terms of the contract, Olink Proteomics AB will test 440 samples using its Olink Target 96 Inflammation protein biomarker panel. The work will be performed in Potomac, Maryland over a one year period concluding in July 2024. As the prime contractor on this firm fixed price contract,...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $51,660 firm fixed price delivery order to Olink Proteomics AB of Watertown, Massachusetts. The order is for services to evaluate circulating biomarkers in cancer in support of the Division of Cancer Epidemiology and Genetics. The award has a period of performance through February 4, 2022. No set-aside provisions were applied to this order issued under an unspecified preexisting contract...
The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $20,481 purchase order to Olink Proteomics Inc. of Waltham, Massachusetts for biological products and services. The firm fixed price contract runs from November 13, 2023 through December 26, 2023 and will support the NIH NCI's research efforts. No subcontractors or set aside designations were identified. Olink Proteomics will provide biological materials to aid the NIH NCI in...
This firm-fixed-price purchase order was awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company. The $13,184 contract is for a service agreement with a completion date of September 21, 2025. Olink Proteomics provides a range of proteomics instruments, reagent kits, integrated fluidic circuits, analysis services, and biological products to support biomedical...
This contract was awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Olink Proteomics AB, a foreign-owned for-profit organization, to provide testing services using inflammation and cardiometabolic panels. The contract has a period of performance from May 1, 2018 to April 30, 2019 and a firm fixed price contract value of $157,489.90. No set-aside designation was indicated. Olink Proteomics AB has provided similar proteomics analysis...
Olink Proteomics AB was awarded a firm fixed price, indefinite delivery contract valued at up to $1,214,788 by the National Institutes of Health National Institute on Drug Abuse to provide biological and reagent materials as well as proteomics analysis services. Specializing in proprietary multiplex protein biomarker analysis technologies, Olink will support biomedical research efforts through delivery of Olink Explore and Target multiplex protein analysis kits, reagents, array chips, and...